CAR T-cell therapy found highly effective in patients with high-risk non-Hodgkin lymphoma ...Middle East

A CAR T-cell therapy known as axicabtagene ciloleucel (axi-cel) drove cancer cells to undetectable levels in nearly 80% of patients with advanced non-Hodgkin lymphoma (NHL) in a phase 2 clinical trial, Dana-Farber Cancer Institute investigators report at the virtual 62nd American Society of Hematology (ASH) Annual Meeting.

Hence then, the article about car t cell therapy found highly effective in patients with high risk non hodgkin lymphoma was published today ( Saturday 05/12/2020 - 09:01 PM ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CAR T-cell therapy found highly effective in patients with high-risk non-Hodgkin lymphoma )

Also on site :

• Your citizens don't stay put in Stellaris-style 4X strategy game Final Vanguard - start a war and "entire waves of refugees can emerge"
• Labour doesn’t care about protecting countryside, voters say
• Shropshire cricket ace lands Warwickshire captaincy role